Eculizumab para el síndrome hemolítico urémico atípico

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2013
RECORD STATUS: This is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available. CITATION: Eculizumab for atypical haemolytic uraemic syndrome. Barcelona: Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA).
Epistemonikos ID: 686d6b76850c8e2f411fff326098c101713cb77d
First added on: Feb 06, 2015